![Serge Braun](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Aktive Positionen von Serge Braun
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Association Française contre les Myopathies
![]() Association Française contre les Myopathies Miscellaneous Commercial ServicesCommercial Services The Association Française contre les Myopathies is a foundation dedicated to the research, treatment, awareness of neuromuscular diseases, aiming to help improve the patients' expectancy and quality of life. They offer services such as diagnostic tests, home therapy support, and enablement programs for education and daily living. The firm was founded in 1958, and is based in Evry. | Technik-/Wissenschafts-/F&E-Leiter | 09.03.2011 | - |
Genosafe SAS
![]() Genosafe SAS Miscellaneous Commercial ServicesCommercial Services Genosafe SAS specializes in evaluating the quality, safety, and efficacy of innovative biological products. Its services are discovery research, preclinical development, quality control (QC) testing, clinical development, analytical development, and regulatory affairs. The company was founded in 2003 and is headquartered in Evry, France. | Vorsitzender | 01.01.2013 | - |
Karriereverlauf von Serge Braun
Ehemalige bekannte Positionen von Serge Braun
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Yposkesi
![]() Yposkesi BiotechnologyHealth Technology Part of SK, Inc., Yposkesi is a French-based CDMO that offers bioprocess development and CGMP manufacturing services for AAV and lentiviral vector production. The company is based in Corbeil-Essonnes, France. The French company provides support for gene therapy and aims to provide the best and most complete viral vector solutions. Yposkesi provides flexibility to develop the best process for cell and gene therapy production and process for viral vector. The company was founded in 2015, and Alain Lamproye has been the CEO of the company since 2017. Yposkesi was acquired by SK Pharmteco, Inc. on March 31, 2021. | Direktor/Vorstandsmitglied | - | - |
Statistik
International
Frankreich | 4 |
Operativ
Chief Tech/Sci/R&D Officer | 1 |
Chairman | 1 |
Director/Board Member | 1 |
Sektoral
Commercial Services | 3 |
Health Technology | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Private Unternehmen | 3 |
---|---|
Association Française contre les Myopathies
![]() Association Française contre les Myopathies Miscellaneous Commercial ServicesCommercial Services The Association Française contre les Myopathies is a foundation dedicated to the research, treatment, awareness of neuromuscular diseases, aiming to help improve the patients' expectancy and quality of life. They offer services such as diagnostic tests, home therapy support, and enablement programs for education and daily living. The firm was founded in 1958, and is based in Evry. | Commercial Services |
Genosafe SAS
![]() Genosafe SAS Miscellaneous Commercial ServicesCommercial Services Genosafe SAS specializes in evaluating the quality, safety, and efficacy of innovative biological products. Its services are discovery research, preclinical development, quality control (QC) testing, clinical development, analytical development, and regulatory affairs. The company was founded in 2003 and is headquartered in Evry, France. | Commercial Services |
Yposkesi
![]() Yposkesi BiotechnologyHealth Technology Part of SK, Inc., Yposkesi is a French-based CDMO that offers bioprocess development and CGMP manufacturing services for AAV and lentiviral vector production. The company is based in Corbeil-Essonnes, France. The French company provides support for gene therapy and aims to provide the best and most complete viral vector solutions. Yposkesi provides flexibility to develop the best process for cell and gene therapy production and process for viral vector. The company was founded in 2015, and Alain Lamproye has been the CEO of the company since 2017. Yposkesi was acquired by SK Pharmteco, Inc. on March 31, 2021. | Health Technology |
- Börse
- Insiders
- Serge Braun
- Erfahrung